These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22125630)

  • 1. Partial depletion of natural CD4⁺CD25⁺ regulatory T cells with anti-CD25 antibody does not alter the course of acute influenza A virus infection.
    Betts RJ; Ho AW; Kemeny DM
    PLoS One; 2011; 6(11):e27849. PubMed ID: 22125630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of anti-CD25 mAb leads to impaired α-galactosylceramide-mediated induction of IFN-γ production in a murine model.
    Rosalia RA; Štěpánek I; Polláková V; Šímová J; Bieblová J; Indrová M; Moravcová S; Přibylová H; Bontkes HJ; Bubeník J; Sparwasser T; Reiniš M
    Immunobiology; 2013 Jun; 218(6):851-9. PubMed ID: 23182710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Foxp3+ CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratory syncytial virus infection.
    Fulton RB; Meyerholz DK; Varga SM
    J Immunol; 2010 Aug; 185(4):2382-92. PubMed ID: 20639494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depletion of natural CD4+CD25+ T regulatory cells with anti-CD25 antibody does not change the course of Pseudomonas aeruginosa-induced acute lung infection in mice.
    Carrigan SO; Yang YJ; Issekutz T; Forward N; Hoskin D; Johnston B; Lin TJ
    Immunobiology; 2009; 214(3):211-22. PubMed ID: 19215803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial depletion of CD69low-expressing natural regulatory T cells with the anti-CD25 monoclonal antibody PC61.
    McNeill A; Spittle E; Bäckström BT
    Scand J Immunol; 2007 Jan; 65(1):63-9. PubMed ID: 17212768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depletion of CD4+CD25+Foxp3+ regulatory T cells with anti-CD25 antibody may exacerbate the 1,3-β-glucan-induced lung inflammatory response in mice.
    Liu F; Weng D; Chen Y; Song L; Li C; Dong L; Wang Y; Tao S; Chen J
    Arch Toxicol; 2011 Nov; 85(11):1383-94. PubMed ID: 21347662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-IL-2 treatment impairs the expansion of T(reg) cell population during acute malaria and enhances the Th1 cell response at the chronic disease.
    Zago CA; Bortoluci KR; Sardinha LR; Pretel FD; Castillo-Méndez SI; Freitas do Rosário AP; Hiyane MI; Muxel SM; Rodriguez-Málaga SM; Abrahamsohn IA; Álvarez JM; D'Império Lima MR
    PLoS One; 2012; 7(1):e29894. PubMed ID: 22272258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astragaloside IV attenuates allergic inflammation by regulation Th1/Th2 cytokine and enhancement CD4(+)CD25(+)Foxp3 T cells in ovalbumin-induced asthma.
    Huang X; Tang L; Wang F; Song G
    Immunobiology; 2014 Jul; 219(7):565-71. PubMed ID: 24731407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo depletion of CD4+CD25+ regulatory T cells in cats.
    Smithberg SR; Fogle JE; Mexas AM; Reckling SK; Lankford SM; Tompkins MB; Dean GA
    J Immunol Methods; 2008 Jan; 329(1-2):81-91. PubMed ID: 17980384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
    Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
    J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MEK-inhibitor treatment reduces the induction of regulatory T cells in mice after influenza A virus infection.
    Koch-Heier J; Vogel AB; Füll Y; Ebensperger M; Schönsiegel A; Zinser RS; Planz O
    Front Immunol; 2024; 15():1360698. PubMed ID: 38979428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-CD25 antibody-mediated depletion of effector T cell populations enhances susceptibility of mice to acute but not chronic Toxoplasma gondii infection.
    Couper KN; Lanthier PA; Perona-Wright G; Kummer LW; Chen W; Smiley ST; Mohrs M; Johnson LL
    J Immunol; 2009 Apr; 182(7):3985-94. PubMed ID: 19299696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of CD4+CD25+ regulatory T cells may underlie enhanced Th1 immunity caused by immunization with activated autologous T cells.
    Cao Q; Wang L; Du F; Sheng H; Zhang Y; Wu J; Shen B; Shen T; Zhang J; Li D; Li N
    Cell Res; 2007 Jul; 17(7):627-37. PubMed ID: 17563757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-CD25 monoclonal antibody Fc variants differentially impact regulatory T cells and immune homeostasis.
    Huss DJ; Pellerin AF; Collette BP; Kannan AK; Peng L; Datta A; Wipke BT; Fontenot JD
    Immunology; 2016 Jul; 148(3):276-86. PubMed ID: 27012310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of CD4+ CD25+ regulatory T cells during early mycobacterial infection increases cytokine production but does not affect pathogen load.
    Quinn KM; McHugh RS; Rich FJ; Goldsack LM; de Lisle GW; Buddle BM; Delahunt B; Kirman JR
    Immunol Cell Biol; 2006 Oct; 84(5):467-74. PubMed ID: 16869940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virus expanded regulatory T cells control disease severity in the Theiler's virus mouse model of MS.
    Richards MH; Getts MT; Podojil JR; Jin YH; Kim BS; Miller SD
    J Autoimmun; 2011 Mar; 36(2):142-54. PubMed ID: 21273044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine melanoma-infiltrating dendritic cells are defective in antigen presenting function regardless of the presence of CD4CD25 regulatory T cells.
    Ataera H; Hyde E; Price KM; Stoitzner P; Ronchese F
    PLoS One; 2011 Mar; 6(3):e17515. PubMed ID: 21390236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-2/anti-IL-2 complexes ameliorate lupus nephritis by expansion of CD4
    Yan JJ; Lee JG; Jang JY; Koo TY; Ahn C; Yang J
    Kidney Int; 2017 Mar; 91(3):603-615. PubMed ID: 27914701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD25-Targeted IL-2 Signals Promote Improved Outcomes of Influenza Infection and Boost Memory CD4 T Cell Formation.
    Alam F; Singh A; Flores-Malavet V; Sell S; Cooper AM; Swain SL; McKinstry KK; Strutt TM
    J Immunol; 2020 Jun; 204(12):3307-3314. PubMed ID: 32376651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic regulation of T follicular regulatory cell responses by interleukin 2 during influenza infection.
    Botta D; Fuller MJ; Marquez-Lago TT; Bachus H; Bradley JE; Weinmann AS; Zajac AJ; Randall TD; Lund FE; León B; Ballesteros-Tato A
    Nat Immunol; 2017 Nov; 18(11):1249-1260. PubMed ID: 28892471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.